Pharmacokinetic Study of a Diclofenac Sodium Capsule Filled with Enteric-coated Pellets in Healthy Chinese Volunteers by Liquid Chromatography-electrospray Ionization-tandem Mass Spectrometry

Abstract

The pharmacokinetic study of a diclofenac sodium capsule filled with enteric-coated pellets (abbreviated as CAPSULE) in healthy Chinese subjects was evaluated using liquid chromatography-electrospray ionization-tandem mass spectrometry with simple sample preparation. In a cross-over study, 12 healthy male volunteers were given 50 mg CAPSULE and diclofenac sodium enteric-coated tablet (abbreviated as TABLET, used as a control dosage form) at fasting. The C_max, AUC_0–t, and T_max of CAPSULE were 1.01±0.52 μg/mL, 1.54±0.18 μg·h/mL, and 1.50±1.31 h, respectively. When compared with TABLET, the pharmacokinetic study showed that although this CAPSULE exhibited similar AUC (only 10% lower), it presented lower maximum plasma concentration, faster absorption and shorter time to reach maximum concentration. When compared with the previous study in Germany, obvious variations on T_max were found in Chinese subjects taking CAPSULE, but not TABLET. The results indicated that individual difference should be paid attention when prescribing CAPSULE to Chinese patients.

Key words

diclofenac sodium - multiple-unit formulation - LC-MS/MS - clinical pharmacokinetics

• References

• 1 Shoutakis VA, Carter CA, Mickle TR et al. Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent. Drug Intell Clin Pharm 1998; 22: 850-859
• 2 Hawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol 2001; 15: 801-820
• 3 Todd PA, Sorkin EM. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988; 35: 244-285
• 4 Schiller C, Frohlich CP, Giessmann T et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic ressonance imaging. Aliment Pharmacol Ther 2005; 22: 971-979
• 5 Ghebre-Sellassie I. Multiparticulate Oral Drug Delivery. New York: Marcel Dekker; 1994
• 6 Hosny EA, El-Mahrouk GM, Gouda MW. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads. Drug Dev Ind Pharm 1998; 24: 661-666
• 7 Scheidel B, Blume H, Walter K et al. Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation. Arzneimittelforschung 1993; 43: 1211-1215
• 8 Scheidel B, Blume H, Walter K et al. The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions. Arzneimittelforschung 1994; 44: 544-550
• 9 Rajnarayana K, Venkatesham A, Krishna DR. Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact 2007; 22: 165-174
• 10 Yolande BS, Taimour L. Genetic Polymorphisms of CYP2C9: Comparison of Prevalence in the Lebanese Population with Other Populations’. Pharmacol Pharm 2011; 2: 88-93
• 11 Avgerinos A, Karidas Th, Malamataris S. Extractionless high-performance liquid chromatographic method for the determination of diclofenac in human plasma and urine. J Chromatogr 1993; 619: 324-329
• 12 Jayanti M, Ayan D, Uday SC et al. Bioequivalence study of a fixed dose combination tablet containing rabeprazole and diclofenac sodium in healthy Indian subjects. Arzneimittelforschung 2010; 60: 506-509
• 13 El-Sayed YM, Mohamed EA, Mohammad SS et al. A rapid and sensitive high-performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetics studies. J pharm Pharmacol 1988; 40: 727-729
• 14 Jones J. LC-MS/MS Method for the Determination of Diclofenac in Human Plasma. Thermo Fisher Scientific. 2012 Online Available at: http://www.thermoscientific.com/content/dam/tfs/ATG/CMD/CMD%20Documents/Application%20%26%20Technical%20Notes/Chromatography%20Columns%20and%20Supplies/HPLC%20Columns/HPLC%20Column%20(Solid%20Core)/AN20569_Method_Human%20Plasma.pdf
• 15 FDA. FDA guidance for industry bioanalytical method validation, revision1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) 2013
• 16 Giagoudakis G, Markantonis SL. An alternative high-performance liquid chromatographic method for the determination of diclofenac and flurbiprofen in plasma. J Pharm Biomed Anal 1998; 17: 897-901
• 17 Alam MA, Al-Jenoobi FI, Al-Mohizea AM et al. Method for Analysis of Diclofenac Sodium in Rabbit Plasma. J Chromatogr Sci J Chromatogr Sci 2015; 53: 47-53
• 18 Van Gelderen ME, Olling M, Barends DM et al. The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity. Biopharm Drug Dispos 1994; 15: 775-788
• 19 Kambayashi A, Blume H, Dressman JB. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium. Eur J Pharm Biopharm 2014; 87: 236-243
• 20 Pal A, Brasseur JG, Abrahamsson B. A stomach road or “Magenstrasse” for gastric emptying. J Biomech 2007; 40: 1202-1210
• 21 Vidon N, Pfeiffer A, Godbillon J et al. Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. Br J Clin Pharmacol 1989; 28: 121-124
• 22 Walter K, von Nieciecki A. Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets. Arzneimittelforschung 2001; 51: 643-650